ETOPOSIDE (VP-16-213)

被引：169

作者：

ISSELL, BF

CROOKE, ST

机构：

[1] Department of Clinical Cancer Research, Bristol Laboratories, Syracuse

来源：

CANCER TREATMENT REVIEWS | 1979年 / 6卷 / 02期

关键词：

D O I：

10.1016/S0305-7372(79)80045-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：107 / 124

页数：18

共 75 条

[1]

AHMANN DL, 1976, CANCER TREAT REP, V60, P1681

[2]

AHMANN DL, 1976, CANCER TREAT REP, V60, P633

[3]

AISNER J, 1977, ADJUVANT THERAPY CAN

[4]

BERNASCONI C, 1976, ERKRANKUNGEN MYELOPO, P224

[5]

BLEYER WA, 1978, P AM ASSOC CANC RES, V19, P373

[6]

BRODER LE, 1978, P AM ASSOC CANC RES, V19, P71

[7]

BRUNNER KW, 1976, CANCER TREAT REP, V60, P1377

[8] EPIPODOPHYLLOTOXIN VP-16213 IN ACUTE NON-LYMPHOBLASTIC LEUKEMIA [J].

CAVALLI, F ;

SONNTAG, R ;

BRUNNER, KW .

BRITISH MEDICAL JOURNAL, 1975, 4 (5990) :227-227

[9]

CAVALLI F, 1978, CANCER TREAT REP, V62, P473

[10] COMBINATION OF CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE AND VP16213 (NSC141540) IN TREATMENT OF BRONCHOGENIC CARCINOMA [J].

CAVALLI, F ;

HASLER, E ;

RYSSEL, HJ ;

SONNTAG, RW ;

BRUNNER, KW .

TUMORI, 1977, 63 (02) :169-173

← 1 2 3 4 5 6 7 8 →